Mr. Tsai is a Partner at Invus Opportunities, a NY-based investment firm with over $1 billion under management, where he has led numerous growth investments in healthcare and technology companies since 2008 and served as a Director or Board Observer of over a dozen companies over that period. Representative life sciences investments include Valtech Cardio and CardiAQ (both sold to Edwards Lifesciences), Kythera and Aquesys (both sold to Allergan). Previously, Mr. Tsai was a management consultant at the Monitor Group, where he advised senior executives of companies globally on their most critical strategic issues. He holds an MBA degree from Harvard Business School and a BS degree from the University of Southern California, where he was a Trustee Scholar.
Mr. Eric Le Royer, MS, MBA serves as Managing Director at Latitude MedSolutions. Mr. Le Royer served as the Chief Executive Officer and President of Endosense SA (acquired by Abbott Vascular) until September 2011. He worked for Guidant from 1989 to 2004. He has held various leadership positions on three continents. In his last three positions, he was the Cardiac Rhythm Management director in Japan, then the General Manager of the Carotid and Peripheral Business Unit in California, and the European Marketing vice president. He is board member of Medyria AG, CardioRenal SAS, Veosource SA and 4tech Inc. Mr. Le Royer received his engineering degree from the Ecole Supérieure d'Electricité in France and a master's degree in electrical engineering from the University of Houston. He also earned a master's degree in business administration from Columbia University.